Question 22904 — pharmacy and medications

Summary

Mr. Stéphane Demilly questions the Minister of Solidarity and Health on the question, too rarely raised, of pharmaceutical independence. In recent months, disruptions in the supply of medicines, sometimes endangering the lives of patients, have increased. According to the National Medicines Agency, there were 868 in 2018. This concerns, for example, ametycin for preventive chemotherapy of recurrences of cancer of the bladder, corticosteroids, antibiotics, treatments for hypertension and heart disease. This unsustainable and unacceptable situation is explained on the one hand by the fact that the active ingredients essential to these medicines are today produced, for 80% of them, outside the European Union and on the other hand, by the just-in-time management carried out by certain laboratories. He would like to know the arrangements situational measures taken to compensate for these health deficiencies and to know its position on a possible relocation to Europe, and specifically to France, of the medicine production chain.

Machine translation from French. The official text remains authoritative.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.